本页面由Tiger Trade Technology Pte. Ltd.提供服务

Castle Biosciences, Inc.

32.89
+0.12500.38%
成交量:6.26万
成交额:204.92万
市值:10.05亿
市盈率:-50.27
高:33.05
开:32.79
低:32.23
收:32.76
52周最高:44.28
52周最低:17.72
股本:3,054.95万
流通股本:2,821.96万
量比:0.46
换手率:0.22%
股息:- -
股息率:- -
每股收益(TTM):-0.6542
每股收益(LYR):-0.8334
净资产收益率:-4.20%
总资产收益率:-1.36%
市净率:2.14
市盈率(LYR):-39.46

数据加载中...

2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities